OMDA

+ Watchlist + Portfolio

Omada Health, Inc.

Recurring revenue Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $20.41
52-Week Range: $10.28 – $26.92
Market Cap: $1.25B
P/E (TTM): 84.88
EPS (TTM): 0.24
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 4.88
PEG Ratio: —
Return on Equity: 1.84%
Return on Assets: -0.09%
Gross Margin: 68.19%
Operating Margin: 4.04%
Profit Margin: 1.39%
Current Ratio: 3.91
Debt/Equity: —
Total Debt: $0.00
Free Cash Flow: $11.92M
Revenue Growth: 43.10%
Earnings Growth: —
Enterprise Value: $1.03B

OMDA Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$89.19M	$122.78M	$169.80M	$260.21M
Cost of Revenue	$46.39M	$52.81M	$66.92M	$89.27M
Gross Profit	$42.79M	$69.97M	$102.88M	$170.94M
Research & Development	$26.17M	$33.74M	$35.92M	$40.68M
Selling, General & Admin	$88.97M	$102.23M	$110.61M	$142.23M
Operating Expenses	$115.14M	$135.97M	$146.53M	$182.91M
Operating Income	-$72.35M	-$66.00M	-$43.65M	-$11.97M
EBITDA	-$63.99M	-$58.36M	-$37.83M	-$4.75M
Pretax Income	-$72.52M	-$67.51M	-$47.14M	-$12.78M
Income Tax	$0.00	$0.00	$0.00	$0.00
Net Income	-$72.52M	-$67.51M	-$47.14M	-$12.78M
Diluted EPS	-1.52	-1.41	-0.85	-0.35
Diluted Shares	47.72M	47.72M	55.74M	36.64M

OMDA Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$168.12M	$115.64M	$76.39M	$222.04M
Receivables	$11.67M	$16.44M	$23.92M	$35.22M
Inventory	$3.54M	$3.61M	$3.30M	$4.49M
Current Assets	$188.56M	$142.88M	$113.06M	$272.93M
Total Assets	$221.80M	$175.08M	$150.89M	$305.41M
Current Liabilities	$34.51M	$43.79M	$53.95M	$75.73M
Long-Term Debt	$28.89M	$29.38M	$29.77M	—
Total Debt	$30.81M	$30.58M	$30.19M	$0.00
Total Liabilities	$66.19M	$76.16M	$535.29M	$75.73M
Retained Earnings	-$329.32M	-$396.83M	-$443.97M	-$456.74M
Shareholders' Equity	$155.60M	$98.92M	-$384.40M	$229.68M
Working Capital	$154.04M	$99.09M	$59.11M	$197.21M

OMDA Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$68.98M	-$49.74M	-$34.18M	$18.25M
Capital Expenditure	-$2.72M	-$2.92M	-$3.86M	-$5.83M
Free Cash Flow	-$71.70M	-$52.66M	-$38.04M	$12.42M
Depreciation & Amortisation	$4.33M	$4.45M	$4.80M	$5.49M
Stock-Based Compensation	$6.65M	$8.74M	$9.42M	$12.96M
Investing Cash Flow	-$2.72M	-$2.92M	-$3.86M	-$5.83M
Financing Cash Flow	$16.32M	$179.00K	-$1.21M	$133.22M
Net Change in Cash	-$55.38M	-$52.48M	-$39.25M	$145.64M

OMDA Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$61.37M	$68.03M	$75.85M	$78.05M	$87.83M
Cost of Revenue	$21.07M	$22.96M	$22.18M	$29.36M	$24.05M
Gross Profit	$40.31M	$45.07M	$53.66M	$48.69M	$63.79M
Research & Development	$10.02M	$10.30M	$11.55M	$12.70M	$14.63M
Selling, General & Admin	$34.63M	$37.28M	$38.83M	$40.78M	$45.61M
Operating Expenses	$44.65M	$47.58M	$50.38M	$53.47M	$60.24M
Operating Income	-$4.34M	-$2.51M	$3.28M	-$4.78M	$3.55M
EBITDA	-$2.87M	-$1.47M	$6.62M	-$1.44M	$6.89M
Pretax Income	-$5.31M	-$3.18M	$5.16M	-$2.97M	$5.29M
Income Tax	$0.00	$0.00	$0.00	$0.00	$0.00
Net Income	-$5.31M	-$3.18M	$5.16M	-$2.97M	$5.29M
Diluted EPS	-0.24	-0.06	0.08	-0.05	0.08
Diluted Shares	21.97M	57.66M	63.93M	58.92M	63.95M

OMDA Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$223.15M	$198.63M	$222.04M	$211.76M	$221.71M
Receivables	$33.29M	$41.45M	$35.22M	$39.98M	$56.57M
Inventory	$3.47M	$3.15M	$4.49M	$3.83M	$4.12M
Current Assets	$271.11M	$254.90M	$272.93M	$269.43M	$294.91M
Total Assets	$302.97M	$287.47M	$305.41M	$302.80M	$328.22M
Current Liabilities	$57.99M	$70.12M	$75.73M	$68.68M	$75.48M
Long-Term Debt	$29.97M	—	—	—	—
Total Debt	$29.97M	$0.00	$0.00	—	—
Total Liabilities	$88.76M	$70.12M	$75.73M	$68.68M	$75.48M
Retained Earnings	-$458.73M	-$461.90M	-$456.74M	-$459.71M	-$454.42M
Shareholders' Equity	$214.21M	$217.35M	$229.68M	$234.12M	$252.74M
Working Capital	$213.12M	$184.78M	$197.21M	$200.75M	$219.43M

OMDA Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$2.86M	$10.13M	$21.38M	-$11.83M	$4.01M
Capital Expenditure	-$1.25M	-$1.99M	-$1.35M	-$1.56M	-$1.66M
Free Cash Flow	$1.61M	$8.15M	$20.03M	-$13.39M	$2.34M
Depreciation & Amortisation	$1.35M	$1.36M	$1.45M	$1.51M	$1.58M
Stock-Based Compensation	$2.83M	$3.54M	$3.75M	$4.21M	$5.63M
Investing Cash Flow	-$1.25M	-$1.99M	-$1.35M	-$1.56M	-$1.66M
Financing Cash Flow	$162.14M	-$32.66M	$3.38M	$3.12M	$7.60M
Net Change in Cash	$163.75M	-$24.52M	$23.41M	-$10.27M	$9.95M

Market Snapshot

About

Omada Health is a virtual care platform specializing in chronic disease management and prevention. The company offers digital programs for prediabetes, diabetes, hypertension, and musculoskeletal conditions combining personalized coaching, curriculum, and connected devices. Omada partners with employers and health plans to deliver care remotely.